JoveWhizz provides market research services across the global healthcare and life sciences sector. The healthcare ecosystem — patients, providers, payers, regulators, and life science companies — has distinct research needs at every level. From clinical decision-making and health technology adoption to patient experience and pharmaceutical market access, JoveWhizz's approach combines methodological rigour with a deep understanding of healthcare systems across developed and emerging markets.
Healthcare research demands a fundamentally different approach from consumer research. The decision-making process is more complex, involving multiple stakeholders, high stakes, and extensive regulatory constraints. Reaching healthcare professionals requires navigating gatekeepers, busy schedules, and strict compliance requirements around data use and engagement incentives. Research involving patients often requires enhanced consent procedures and additional safeguards for personal health information. Healthcare systems vary dramatically between countries — the insurance-driven US market, publicly funded systems in the UK and Canada, social health insurance models in Germany and France, and out-of-pocket-driven systems in parts of Africa and Asia. Each system requires different research instruments and approaches. These characteristics require research partners who understand the healthcare landscape, the relevant regulations, and the appropriate methods for each stakeholder group.
Understanding the full patient journey — from symptom recognition and information seeking through diagnosis, treatment, and follow-up — is essential for improving care delivery and patient outcomes. In value-based care systems such as the United States, patient satisfaction scores directly affect provider reimbursement. In publicly funded systems in Canada, the United Kingdom, and Australia, our research addresses wait times, referral pathways, and the experience of accessing specialist and emergency care. In markets with mixed public-private systems such as Germany, France, the Netherlands, Switzerland, and India, we study the factors driving patients to choose private care over public provision and measure satisfaction across both sectors.
Reaching physicians, nurses, hospital administrators, and allied health professionals requires research approaches that respect their time constraints and regulatory environment. We conduct physician satisfaction studies, practice management surveys, and research on the adoption of digital health tools including electronic health records, telemedicine platforms, clinical decision support systems, and AI-assisted diagnostics. In emerging markets such as India, Brazil, Mexico, Indonesia, and Kenya, our research addresses healthcare access, the role of private healthcare providers, and the impact of health insurance expansion on service utilisation patterns.
Companies bringing new medical devices, diagnostics, digital health solutions, and therapeutics to market need to understand willingness to adopt, willingness to pay, and the factors that influence clinical and purchasing decisions across different healthcare systems and reimbursement environments. HTA-related research requires understanding of market access environments, payer expectations, and healthcare decision-making processes across markets. We evaluate product concepts, pricing sensitivity, and adoption barriers across the US, Europe, Asia-Pacific, Latin America, and Africa.
Pharmaceutical research spans the product lifecycle from early concept testing through launch tracking and post-market surveillance. We conduct prescribing behaviour studies, patient-reported outcome research, market access and reimbursement studies, and brand tracking among prescribing physicians. The research must navigate strict regulations around data collection from healthcare professionals, adverse event reporting obligations, and restrictions on incentives for participation.
United States: Research must address the insurance-driven system, value-based care, HIPAA compliance, and the complex payer-provider-patient dynamic. Patient satisfaction scores directly affect reimbursement under Medicare's value-based programs. Healthcare professional research requires navigating institutional review boards, credentialing processes, and compliance with the Sunshine Act disclosure requirements.
Europe (UK, Germany, France, Netherlands, Switzerland, Nordic countries): Public and social health insurance systems require research on access pathways, referral processes, and the private versus public care decision. GDPR compliance adds specific consent requirements. Cross-country studies must account for different healthcare system structures and cultural attitudes toward healthcare.
Asia-Pacific (Japan, South Korea, Singapore, India, China, Australia): Rapidly aging populations in Japan and South Korea create demand for research on elderly care, chronic disease management, and health technology adoption. India and Southeast Asia require research on healthcare access, medical tourism, and the expanding private healthcare sector. Australia's mixed public-private system shares characteristics with European models.
Latin America (Brazil, Mexico, Colombia, Argentina, Chile): Growing middle classes and expanding health insurance coverage create research demand around healthcare access, quality perceptions, and willingness to pay for private care. The public-private mix varies significantly by country.
Africa and Middle East (South Africa, Nigeria, Kenya, UAE, Saudi Arabia): Emerging healthcare markets require research on health insurance adoption, private healthcare utilisation, mobile health (mHealth) adoption, and healthcare access challenges. The UAE and Saudi Arabia are investing heavily in healthcare infrastructure, creating demand for research on patient expectations and provider recruitment.
Patient journey research maps the complete care pathway from the patient's perspective, identifying pain points, information gaps, and opportunities for improved care delivery. Key elements include pathway mapping from symptom onset through diagnosis, treatment, and follow-up; satisfaction measurement across touchpoints covering clinical care, administrative processes, facility environment, and billing; experience with specific conditions including chronic disease management, cancer care, maternal health, and outpatient surgery; and digital health engagement including telemedicine satisfaction, patient portal usage, and adoption of health tracking devices. Patient-reported outcome measures (PROMs) and patient-reported experience measures (PREMs) are integrated into our research design where appropriate.
Healthcare research operates under some of the strictest regulatory frameworks in market research. HIPAA in the United States governs the use and disclosure of protected health information. GDPR in Europe requires explicit consent for processing health data, which is classified as a special category of data. Sunshine Act and similar transparency laws require disclosure of payments and transfers of value to healthcare professionals. IRB (Institutional Review Board) approval may be required for research involving patients, particularly clinical research. Adverse event reporting obligations mean research instruments must include appropriate mechanisms for identifying and reporting potential adverse events. JoveWhizz builds compliance into every healthcare research project, with consent mechanisms, data handling procedures, and reporting protocols designed to align with applicable regulatory requirements.
JoveWhizz combines global research standards with deep understanding of healthcare systems across developed and emerging markets. Our team is experienced in navigating the regulatory complexity of healthcare research, from HIPAA and GDPR compliance to IRB protocols and adverse event reporting. We have recruited and interviewed healthcare professionals across North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East for studies spanning pharmaceuticals, medical devices, digital health, and health system performance. Our clients choose us because we deliver healthcare research that meets rigorous methodological standards while respecting the regulatory environment and the demands of clinical practice.
What compliance regulations apply to healthcare market research?
HIPAA (US), GDPR (Europe), Sunshine Act disclosure requirements, IRB protocols for patient research, and adverse event reporting obligations. The specific framework depends on the country, the respondent type, and the nature of the study.
How do you recruit healthcare professionals for research?
We use specialist HCP panels, professional networks, medical association partnerships, and conference-based recruitment. All recruitment follows applicable compliance requirements, including appropriate incentives that meet regulatory guidelines.
Can you conduct multi-country healthcare studies?
Yes. We have experience conducting healthcare research across North America, Europe, Asia-Pacific, Latin America, Africa, and the Middle East. Multi-country studies require coordinating different regulatory frameworks, healthcare systems, and cultural contexts.
Do you conduct research with physicians and healthcare professionals?
Yes. JoveWhizz conducts research with physicians, nurses, pharmacists, hospital administrators, payers, and other healthcare professionals through specialist recruitment methodologies that comply with applicable regulations and transparency requirements.
What is the difference between patient experience and patient satisfaction research?
Patient experience research measures what actually happened during care delivery, while patient satisfaction measures whether expectations were met. Both are important but require different research instruments and analytical approaches. We integrate both where appropriate.
Planning a healthcare market research project? Contact JoveWhizz to discuss your objectives, target audience, and methodology requirements. Our team can support studies across pharmaceuticals, medical devices, digital health, patient experience, and health system performance in markets worldwide.
Contact Us